Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 4/2006

01-04-2006 | Original Article

Quality of life in terminal care—with special reference to age, gender and marital status

Authors: C. Lundh Hagelin, Åke Seiger, C. J. Fürst

Published in: Supportive Care in Cancer | Issue 4/2006

Login to get access

Abstract

Objectives

This study was conducted to explore symptoms, other quality of life (QoL) aspects and impact of age, gender, marital status, cancer diagnosis and time of survival in patients with advanced cancer admitted to palliative care.

Patients and methods

A cross-sectional study of 278 cancer patients completing the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 at referral to palliative care.

Main results

Gynaecological and gastro-intestinal tract cancers were the most common. Mean age was 67 years; 62% were female. Median survival was 43 days and 39% lived less than 30 days. Patients reported impaired general QoL and high occurrence of symptoms (44 and 100% for diarrhoea and fatigue, respectively). Fatigue, appetite loss and dyspnoea were reported as most severe (mean values of 80, 59 and 51, respectively, 0–100 scales). Married/cohabiting patients and younger patients reported lower functional abilities and more symptoms. No impact of diagnoses on QoL parameters was found. Patients closest to death did not differ significantly from those with longer time to live in social functioning.

Conclusion

Young and married patients may be at higher risk for perceived low quality of life at the end of life. EORTC QLQ-C30 could be used as a clinical tool for screening of symptoms and reduced functioning in palliative care, but may not be appropriate for use in the most severely ill patients. Limitations of the instrument and the need for robust measurements of patient mix are discussed. Proxy ratings of physical symptoms and nurse responsibility to include QoL assessment in daily practice would increase attrition and decrease selection bias.
Literature
1.
Aaronson N, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez N et al (1993) The EORTC QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376PubMedCrossRef
2.
Albert US, Koller M, Lorenz W, Kopp I, Heitmann C, Stinner B, Rothmund M, Schulz KD (2002) Quality of life profile: from measurement to clinical application. Breast 11(4):324–334PubMedCrossRef
3.
Axelsson B, Sjoden PO (1999) Assessment of quality of life in palliative care—psychometric properties of a short questionnaire. Acta Oncol 38(2):229–237PubMedCrossRef
4.
Beck-Friis B, Strang P, Eklund G (1989) Physical dependence of cancer patients at home. Palliat Med 3:281–286CrossRef
5.
Bergman B, Sullivan M, Sorenson S (1992) Quality of life during chemotherapy for small cell lung cancer. II. A longitudinal study of the EORTC core quality of life questionnaire and comparison with the sickness impact profile. Acta Oncol 31(1):19–28PubMedCrossRef
6.
Bjordal K, de Graeff A, Fayers PM, Hammerlid E, van Pottelsberghe C, Curran D, Ahlner-Elmqvist M, Maher EJ, Meyza JW, Bredart A, Soderholm AL, Arraras JJ, Feine JS, Abendstein H, Morton RP, Pignon T, Huguenin P, Bottomly A, Kaasa S (2000) A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. Eur J Cancer 36(14):1796–1807PubMedCrossRef
7.
Bond Sutton L, Erlen JA, Glad JM, Siminoff LA (2003) Recruiting vulnerable populations for research: revisiting the ethical issues. J Prof Nurs 19(2):106–112PubMedCrossRef
8.
Borghede G, Karlsson J, Sullivan M (1997) Quality of life in patients with prostatic cancer: results from a Swedish population study. J Urol 158(4):1477–1485; discussion 1486PubMedCrossRef
9.
Bruera E, Miller L, McCallion J, Macmillan K, Krefting L, Hanson J (1992) Cognitive failure in patients with terminal cancer: a prospective study. J Pain Symptom Manage 7(4):192–195PubMedCrossRef
10.
Carlsson M, Hamrin E (1996) Measurement of quality of life in women with breast cancer. Development of a life satisfaction questionnaire (LSQ-32) and a comparison with the EORTC QLQ-C30. Qual Life Res 5(2):265–274PubMedCrossRef
11.
Casarett DJ, Inouye SK (2001) Diagnosis and management of delirium near the end of life. Ann Intern Med 135(1):32–40PubMed
12.
Coates A, Porzsolt F, Osoba D (1997) Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. Eur J Cancer 33(7):1025–1030PubMedCrossRef
13.
Cohen SR, Boston P, Mount BM, Porterfield P (2001) Changes in quality of life following admission to palliative care units. Palliat Med 15(5):363–371PubMedCrossRef
14.
Curt GA (2000) Impact of fatigue on quality of life in oncology patients. Semin Hematol 37(4 Suppl 6):14–17PubMedCrossRef
15.
de Graeff A, de Leeuw JR, Ros WJ, Hordijk GJ, Blijham GH, Winnubst JA (2001) Sociodemographic factors and quality of life as prognostic indicators in head and neck cancer. Eur J Cancer 37(3):332–339PubMedCrossRef
16.
de Jong N, Candel MJ, Schouten HC, Abu-Saad HH, Courtens AM (2004) Prevalence and course of fatigue in breast cancer patients receiving adjuvant chemotherapy. Ann Oncol 15(6):896–905PubMedCrossRef
17.
Detmar SB, Muller MJ, Schornagel JH, Wever LD, Aaronson NK (2002) Health‐related quality‐of‐life assessments and patient physician communication: a randomized controlled trial. JAMA 288(23):3027–3034 (reprinted)PubMedCrossRef
18.
Dibble SL, Padilla GV, Dodd MJ, Miaskowski C (1998) Gender differences in the dimensions of quality of life. Oncol Nurs Forum 25(3):577–583PubMed
19.
Dimeo F, Stieglitz RD, Novelli-Fischer U, Fetscher S, Mertelsmann R, Keul J (1997) Correlation between physical performance and fatigue in cancer patients. Ann Oncol 8(12):1251–1255PubMedCrossRef
20.
Dimeo FC, Stieglitz RD, Novelli-Fischer U, Fetscher S, Keul J (1999) Effects of physical activity on the fatigue and psychologic status of cancer patients during chemotherapy. Cancer 85(10):2273–2277PubMedCrossRef
21.
Donnelly S, Walsh D (1996) Quality of life assessment in advanced cancer. Palliat Med 10(4):275–283PubMedCrossRef
22.
Fayers P, Aaronson N, Bjordal K, Sullivan M (1995) EORTC QLQ-C30, scoring manual. Quality of Life Unit, EORTC Data Center, EORTC Quality of Life Study Group, Brussels
23.
Friedrichsen M, Erichsen E (2004) The lived experience of constipation in cancer patients in palliative hospital-based home care. Int J Palliat Nurs 10(7):321–325PubMed
24.
Higginson IJ, Carr AJ (2001) Measuring quality of life: using quality of life measures in the clinical setting. BMJ 322(7297):1297–1300PubMedCrossRef
25.
Hjermstad MJ, Fayers PM, Bjordal K, Kaasa S (1998) Health-related quality of life in the general Norwegian population assessed by the European organization for research and treatment of cancer core quality-of-life questionnaire: the QLQ=C30 (+3). J Clin Oncol 16(3):1188–1196PubMed
26.
Hjermstad MJ, Fayers PM, Bjordal K, Kaasa S (1998) Using reference data on quality of life—the importance of adjusting for age and gender, exemplified by the EORTC QLQ-C30 (+3). Eur J Cancer 34(9):1381–1389PubMedCrossRef
27.
Jenkins CA, Schulz M, Hanson J, Bruera E (2000) Demographic, symptom, and medication profiles of cancer patients seen by a palliative care consult team in a tertiary referral hospital. J Pain Symptom Manage 19(3):174–184PubMedCrossRef
28.
Jordhoy MS, Fayers P, Loge JH, Saltnes T, Ahlner-Elmqvist M, Kaasa S (2001) Quality of life in advanced cancer patients: the impact of sociodemographic and medical characteristics. Br J Cancer 85(10):1478–1485PubMedCrossRef
29.
Jordhoy MS, Kaasa S, Fayers P, Ovreness T, Underland G, Ahlner-Elmqvist M (1999) Challenges in palliative care research; recruitment, attrition and compliance: experience from a randomized controlled trial. Palliat Med 13(4):299–310PubMedCrossRef
30.
Kaasa S, Bjordal K, Aaronson N, Moum T, Wist E, Hagen S, Kvikstad A (1995) The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy. Eur J Cancer 31A(13–14):2260–2263PubMedCrossRef
31.
Knobel H, Loge JH, Brenne E, Fayers P, Hjermstad MJ, Kaasa S (2003) The validity of EORTC QLQ-C30 fatigue scale in advanced cancer patients and cancer survivors. Palliat Med 17(8):664–672PubMed
32.
Larsson G, von Essen L, Sjoden PO (1998) Quality of life in patients with endocrine tumors of the gastrointestinal tract: patient and staff perceptions. Cancer Nurs 21(6):411–420PubMedCrossRef
33.
34.
Lo RS, Woo J, Zhoc KC, Li CY, Yeo W, Johnson P, Mak Y, Lee J (2002) Quality of life of palliative care patients in the last two weeks of life. J Pain Symptom Manage 24(4):388–397PubMedCrossRef
35.
Magnusson K, Karlsson E, Palmblad C, Leitner C, Paulson A (1997) Swedish nurses’ estimation of fatigue as a symptom in cancer patients—report of a questionnaire. Eur J Cancer Care (Engl) 6(3):186–191CrossRef
36.
Michelson H, Bolund C, Nilsson B, Brandberg Y (2000) Health-related quality of life measured by the EORTC QLQ-C30—reference values from a large sample of Swedish population. Acta Oncol 39(4):477–484PubMedCrossRef
37.
Mor V, Allen S, Malin M (1994) The psychosocial impact of cancer on older versus younger patients and their families. Cancer 74(7 Suppl):2118–2127PubMedCrossRef
38.
World Health Organisation (1990) Cancer pain relief and palliative care. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 804:1–75
39.
Osoba D, Zee B, Pater J, Warr D, Latreille J, Kaizer L (1997) Determinants of postchemotherapy nausea and vomiting in patients with cancer. Quality of life and symptom control committees of the national cancer institute of canada clinical trials group. J Clin Oncol 15(1):116–123PubMed
40.
Plunkett TA, Chrystal KF, Harper PG (2003) Quality of life and the treatment of advanced lung cancer. Clin Lung Cancer 5(1):28–32PubMedCrossRef
41.
Rivadeneira DE, Evoy D, Fahey TJ III, Lieberman MD, Daly JM (1998) Nutritional support of the cancer patient. CA Cancer J Clin 48(2):69–80PubMedCrossRef
42.
Sahlberg-Blom E, Ternestedt BM, Johansson JE (2001) Is good ‘quality of life’ possible at the end of life? An explorative study of the experiences of a group of cancer patients in two different care cultures. J Clin Nurs 10(4):550–562PubMedCrossRef
43.
Schwarz R, Hinz A (2001) Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 37(11):1345–1351PubMedCrossRef
44.
Sepulveda C, Marlin A, Yoshida T, Ullrich A (2002) Palliative care: the World Health Organization’s global perspective. J Pain Symptom Manage 24(2):91–96PubMedCrossRef
45.
Sigurdardottir V, Bolund C, Brandberg Y, Sullivan M (1993) The impact of generalized malignant melanoma on quality of life evaluated by the EORTC questionnaire technique. Qual Life Res 2(3):193–203PubMedCrossRef
46.
Sprangers MA, Cull A, Groenvold M, Bjordal K, Blazeby J, Aaronson NK (1998) The European Organization for Research and Treatment of Cancer approach to developing questionnaire modules: an update and overview. EORTC Quality of Life Study Group. Qual Life Res 7(4):291–300PubMedCrossRef
47.
Stromgren AS, Goldschmidt D, Groenvold M, Petersen MA, Jensen PT, Pedersen L, Hoermann L, Helleberg C, Sjogren P (2002) Self-assessment in cancer patients referred to palliative care: a study of feasibility and symptom epidemiology. Cancer 94(2):512–520PubMedCrossRef
48.
Stromgren AS, Groenvold M, Pedersen L, Olsen AK, Sjogren P (2002) Symptomatology of cancer patients in palliative care: content validation of self-assessment questionnaires against medical records. Eur J Cancer 38(6):788–794PubMedCrossRef
49.
Stromgren AS, Groenvold M, Pedersen L, Olsen AK, Spile M, Sjogren P (2001) Does the medical record cover the symptoms experienced by cancer patients receiving palliative care? A comparison of the record and patient self-rating. J Pain Symptom Manage 21(3):189–196PubMedCrossRef
50.
Stromgren AS, Groenvold M, Sorensen A, Andersen L (2001) Symptom recognition in advanced cancer. A comparison of nursing records against patient self-rating. Acta Anaesthesiol Scand 45(9):1080–1085PubMedCrossRef
51.
Tishelman C, Degner LF, Mueller B (2000) Measuring symptom distress in patients with lung cancer. A pilot study of experienced intensity and importance of symptoms. Cancer Nurs 23(2):82–90PubMedCrossRef
52.
Tishelman C, Taube A, Sachs L (1991) Self-reported symptom distress in cancer patients: reflections of disease, illness or sickness? Soc Sci Med 33(11):1229–1240PubMedCrossRef
53.
Ulander K, Jeppsson B, Grahn G (1997) Quality of life and independence in activities of daily living preoperatively and at follow-up in patients with colorectal cancer. Support Care Cancer 5(5):402–409PubMedCrossRef
54.
Wagner LI, Cella D (2004) Fatigue and cancer: causes, prevalence and treatment approaches. Br J Cancer 91(5):822–828PubMed
55.
Walsh D, Donnelly S, Rybicki L (2000) The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients. Support Care Cancer 8(3):175–179PubMedCrossRef
56.
Wan GJ, Counte MA, Cella DF (1997) The influence of personal expectations on cancer patients’ reports of health-related quality of life. Psychooncology 6(1):1–11PubMedCrossRef
Metadata
Title
Quality of life in terminal care—with special reference to age, gender and marital status
Authors
C. Lundh Hagelin
Åke Seiger
C. J. Fürst
Publication date
01-04-2006
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 4/2006
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-005-0886-4

Other articles of this Issue 4/2006

Supportive Care in Cancer 4/2006 Go to the issue

Short Communication

Brief oral cryotherapy for the prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplant recipients

Original Article

Dying with dignity according to Swedish medical students

Editorial

Communication and phase 1 clinical trial recruitment

Short Communication

External nasal dilator strips (ENDS) may improve breathlessness in cancer patients

Original Article

An assessment of aetiology-based guidelines for the management of nausea and vomiting in patients with advanced cancer

Original Article

Relevance of philosophy of life and optimism for psychological distress among individuals in a stage where death is approaching
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits